Jennifer Vazquez
Primary Care · Chicago, ILNPI 1598302341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,558, 2.5 times the $617 reported in 2021. Among primary care clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $30.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$818
- AstraZeneca$564
- GSK$368
- Madrigal Pharmaceuticals$355
- Bayer$340
- Boston Scientific$334
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,490100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $818 |
| AstraZeneca | 28 | $564 |
| GSK | 14 | $368 |
| Madrigal Pharmaceuticals | 5 | $355 |
| Bayer | 17 | $340 |
| Boston Scientific | 5 | $334 |
| Lilly USA, LLC | 13 | $309 |
| Abbott | 7 | $222 |
| Boehringer Ingelheim | 5 | $206 |
| Kerecis Limited | 1 | $191 |
| Johnson & Johnson | 6 | $177 |
| Seqirus USA Inc | 7 | $160 |
| Smith+Nephew | 1 | $147 |
| Viiv Healthcare Company | 1 | $130 |
| E.r. Squibb & Sons, L.L.C. | 5 | $127 |
| Pfizer | 5 | $117 |
| Edwards Lifesciences | 1 | $114 |
| Amgen | 5 | $113 |
| Incyte Corporation | 1 | $112 |
| Exact Sciences | 4 | $101 |
| Novartis | 4 | $98 |
| AbbVie | 3 | $50 |
| Dexcom, Inc. | 1 | $49 |
| Astellas Pharma US Inc | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Lucid Diagnostics Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Intuity Medical Inc | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Medicomp Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Wound$191
- Kerecis Omega3 Surgibind$191
- Kerecis Omega3 GraftGuide$191
- Kerecis Omega3 SurgiClose$191
- GRAFIX PL$147
- Oasis$147
- RENASYS GO v2 HOME$147
- COLLAGENASE SANTYL$147
- Stravix$147
- WATCHMAN Access System$137
- SpyGlass Discover$133
- DOVATO$130
- Ozempic$124
- REZDIFFRA$115
- SAPIEN 3 Ultra RESILIA$114
- JAKAFI$112
- FREESTYLE LIBRE 3$110
- JARDIANCE$108
- RYBELSUS$100
How this compares
$5,490 in reported general payments places this provider in the 90th percentile of 150 primary care providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $88,316 |
| OzempicSemaglutide | 31 | $43,349 |
| JardianceEmpagliflozin | 43 | $39,025 |
| JanuviaSitagliptin Phosphate | 25 | $25,525 |
| FarxigaDapagliflozin Propanediol | 15 | $21,328 |
| XareltoRivaroxaban | 14 | $19,163 |
| EntrestoSacubitril/Valsartan | 11 | $4,556 |
| Atorvastatin Calcium | 295 | $3,316 |
| Levothyroxine Sodium | 247 | $3,312 |
| Amlodipine Besylate | 243 | $2,251 |
| Metoprolol Succinate | 120 | $1,705 |
| Gabapentin | 90 | $1,349 |
| Pantoprazole Sodium | 114 | $1,346 |
| Tamsulosin Hcl | 74 | $1,273 |
| Bethanechol Chloride | 15 | $1,229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $88,316103 claims |
| Novo NordiskOzempic | $818 | $43,34931 claims |
| Boehringer IngelheimJardiance | $206 | $39,02543 claims |
| AstraZenecaFarxiga | $564 | $21,32815 claims |
| Johnson & JohnsonXarelto | $177 | $19,16314 claims |
| NovartisEntresto | $98 | $4,55611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 150 primary care providers in Illinois.
Other primary care in Chicago
- Allison LindstromChicago$15K
- Dawn ConwayChicago$11K
- Ashley CarterChicago$7K
- Lauren CiminoChicago$4K
- Yasmin FayazChicago$3K
- Bridget FlanaganChicago$3K
- Ecaterina ZamfirChicago$2K
- Elena IgnatievChicago$2K
- Reem ZayadChicago$2K
- Sarah MasseyChicago$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.